Recursion Pharmaceuticals News - September 2026

🟢 Recursion Pharmaceuticals is trading 4% up today after Tempus committed $42 million in payments

Recursion Pharmaceuticals is trading at $3.98 (+4.05%) on September 21, 2026, after expanding its Tempus AI partnership and licensing its TxFM RNA sequencing...

🟢 Recursion Pharmaceuticals is trading 10.91% up today as biotech rises 2.55%

Recursion Pharmaceuticals is trading 10.91% up at $3.54, primarily amid biotech-sector strength; no clear company-specific announcement was identified for...